AAAAAA
Results:
1-24
|
Results: 24
Authors:
Mather, SJ
Citation: Sj. Mather, Innovation in radiopharmacy: progress and constraints?, EUR J NUCL, 28(4), 2001, pp. 405-407
Authors:
Pouget, JP
Mather, SJ
Citation: Jp. Pouget et Sj. Mather, General aspects of the cellular response to low- and high-LET radiation, EUR J NUCL, 28(4), 2001, pp. 541-561
Authors:
Mather, SJ
Westera, G
Citation: Sj. Mather et G. Westera, Education in radiopharmacy and radiopharmaceutical chemistry: recent developments, EUR J NUCL, 28(3), 2001, pp. BP48-BP50
Authors:
Stalteri, MA
Mather, SJ
Citation: Ma. Stalteri et Sj. Mather, Hybridization and cell uptake studies with radiolabelled antisense oligonucleotides, NUCL MED C, 22(11), 2001, pp. 1171-1179
Authors:
Wilkinson, RW
Ross, EL
Poulsom, R
Ilyas, M
Straub, J
Snary, D
Bodmer, WF
Mather, SJ
Citation: Rw. Wilkinson et al., Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors, P NAS US, 98(18), 2001, pp. 10256-10260
Authors:
Steeds, C
Mather, SJ
Citation: C. Steeds et Sj. Mather, Fasting regimens for regional ophthalmic anaesthesia - A survey of membersof the British Ophthalmic Anaesthesia Society, ANAESTHESIA, 56(7), 2001, pp. 638-642
Authors:
Feneley, MR
Jan, H
Granowska, M
Mather, SJ
Ellison, D
Glass, J
Coptcoat, M
Kirby, RS
Ogden, C
Oliver, RTD
Badenoch, DF
Chinegwundoh, FI
Nargund, VH
Paris, AMI
Britton, KE
Citation: Mr. Feneley et al., Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer, PROSTATE C, 3(1), 2000, pp. 47-52
Authors:
Ellison, D
Stalteri, MA
Mather, SJ
Citation: D. Ellison et al., Photoreduction of monoclonal antibodies for conjugation and fragmentation, BIOTECHNIQU, 28(2), 2000, pp. 318
Authors:
Decristoforo, C
Mather, SJ
Cholewinski, W
Donnemiller, E
Riccabona, G
Moncayo, R
Citation: C. Decristoforo et al., Tc-99m-EDDA/HYNIC-TOC: a new Tc-99-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with In-111-labelled octreotide derivatives, EUR J NUCL, 27(9), 2000, pp. 1318-1325
Authors:
Decristoforo, C
Cholewinski, W
Donnemiller, E
Riccabona, G
Moncayo, R
Mather, SJ
Citation: C. Decristoforo et al., Detection of somatostatin receptor-positive tumours using the new Tc-99m-tricine-HYNIC-D-Phe(1)-Tyr(3)-octreotide: first results in patients and comparison with In-111-DTPA-D-Phe(1)-octreotide, EUR J NUCL, 27(10), 2000, pp. 1580-1580
Authors:
Needleman, I
Mather, SJ
Martin, GP
Sobnack, R
Citation: I. Needleman et al., Periodontal pocket clearance by gamma scintigraphy in human volunteers, J CLIN PER, 27(12), 2000, pp. 904-909
Authors:
Decristoforo, C
Melendez-Alafort, L
Sosabowski, JK
Mather, SJ
Citation: C. Decristoforo et al., Tc-99m-HYNIC-[Tyr(3)]-octreotide for imaging somatostatin-receptor-positive tumors: Preclinical evaluation and comparison with In-111-octreotide, J NUCL MED, 41(6), 2000, pp. 1114-1119
Authors:
Trejtnar, F
Laznicek, M
Laznickova, A
Mather, SJ
Citation: F. Trejtnar et al., Pharmacokinetics and renal handling of Tc-99m-labeled peptides, J NUCL MED, 41(1), 2000, pp. 177-182
Authors:
Abram, WP
Buxton-Thomas, M
Carty, HML
Clarke, SEM
Coakley, AJ
Cunningham, D
Ell, P
Elliott, AT
Frier, M
Gordon, I
Gibson, CJ
Gillen, GJ
Harding, LK
Henk, JM
Hesslewood, SR
Kendall, GM
Lewington, V
McCready, VR
Mather, SJ
McKillop, JH
Millar, A
Mountford, P
Nunan, T
Palmer, M
Pippard, M
Prescott, MC
Shields, RA
Stather, JW
Stocks, MA
Thomas, WH
Tindale, W
Waller, DG
Watkinson, JC
Citation: Wp. Abram et al., Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources, NUCL MED C, 21, 2000, pp. III
Authors:
Mather, SJ
Citation: Sj. Mather, Radiolabelled peptides - promises and pitfalls, NUCL MED C, 21(6), 2000, pp. 507-509
Authors:
Decristoforo, C
Mather, SJ
Citation: C. Decristoforo et Sj. Mather, Preparation, Tc-99m-labeling, and in vitro characterization of hynic and N3S modified RC-160 and [TYR3]octreotide (vol 10, pg 437, 1999), BIOCONJ CHE, 10(4), 1999, pp. 701-702
Authors:
Decristoforo, C
Mather, SJ
Citation: C. Decristoforo et Sj. Mather, Preparation, Tc-99m-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr(3)]octreotide, BIOCONJ CHE, 10(3), 1999, pp. 431-438
Authors:
Stalteri, MA
Bansal, S
Hider, R
Mather, SJ
Citation: Ma. Stalteri et al., Comparison of the stability of technetium-labeled peptides to challenge with cysteine, BIOCONJ CHE, 10(1), 1999, pp. 130-136
Authors:
Decristoforo, C
Mather, SJ
Citation: C. Decristoforo et Sj. Mather, 99m-technetium-labelled peptide-HYNIC conjugates: Effects of lipophilicityand stability on biodistribution, NUCL MED BI, 26(4), 1999, pp. 389-396
Authors:
Stewart, LM
Young, S
Watson, G
Mather, SJ
Bates, PA
Band, HA
Wilkinson, RW
Ross, EL
Snary, D
Citation: Lm. Stewart et al., Humanisation and characterisation of PR1A3, a monoclonal antibody specificfor cell-bound carcinoembryonic antigen, CANCER IMMU, 47(6), 1999, pp. 299-306
Authors:
Decristoforo, C
Mather, SJ
Citation: C. Decristoforo et Sj. Mather, Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence, EUR J NUCL, 26(8), 1999, pp. 869-876
Authors:
Westera, G
Mather, SJ
Johannsen, B
Citation: G. Westera et al., Postgraduate education of persons responsible for the small-scale production and quality control of radiopharmaceuticals (radiopharmaceutical chemists, radiopharmacists): current status, EUR J NUCL, 26(3), 1999, pp. BP8-BP9
Authors:
Morris, EAJ
Mather, SJ
Citation: Eaj. Morris et Sj. Mather, A survey of pre-operative fasting regimens before regional ophthalmic anaesthesia in three regions of the United Kingdom, ANAESTHESIA, 54(12), 1999, pp. 1216-1219
Authors:
Morris, EAJ
Mather, SJ
Citation: Eaj. Morris et Sj. Mather, Oral intake before regional anaesthesia, ANAESTHESIA, 53(11), 1998, pp. 1134-1135
Risultati:
1-24
|